Literature DB >> 6107679

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians.

D J Pettitt, W C Knowler, J R Lisse, P H Bennett.   

Abstract

The risks of microvascular complications over periods of 3 and 6 years in relation to baseline plasma glucose concentrations were estimated in Pima Indians of Arizona aged 25 years or more and who were not taking hypoglycaemic medicine at their initial examinations. Retinopathy (microaneurysms, haemorrhages, or neovascularisation) developed within 3 years in 1% of 181 subjects with initial fasting plasma glucose concentrations less than 140 mg/dl (1 mg/dl = 0.0555 mmol/l) and in 13% of 39 subjects with higher initial fasting plasma glucose levels. No one with an initial 2 h glucose concentration less than 200 mg/dl had retinopathy within 3 years, but the rate was 12% in 60 subjects with higher glucose concentrations. Retinopathy developed within 6 years in 1% of 446 subjects whose 2 h post-load glucose concentrations were less than 200 mg/dl and in 20% of 113 subjects with higher levels. Subsequent development of heavy proteinuria (urine protein/creatinine ratio at least 1.0) was less common than that of retinopathy, but was similarly related to the initial fasting and 2 h plasma glucose concentrations. The finding that these microvascular complications rarely appeared in individuals with fasting plasma glucose concentrations less than 140 mg/dl or 2 h plasma glucose concentrations less than 200 mg/dl supports the validity of these concentrations as part of the new diagnostic criteria for diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107679     DOI: 10.1016/s0140-6736(80)92274-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

1.  Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes.

Authors:  M B Davidson; D L Schriger; A L Peters; B Lorber
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

2.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

3.  Retinopathy in a population-based study.

Authors:  R Klein
Journal:  Trans Am Ophthalmol Soc       Date:  1992

4.  The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial.

Authors:  K L Ivey; J M Hodgson; D A Kerr; J R Lewis; P L Thompson; R L Prince
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

5.  Examination of the fasting and 2-h plasma glucose in the light of impairment in beta-cell function: what does the epidemiological data tell us?

Authors:  Suhail A R Doi; Glenn M Ward
Journal:  Endocrine       Date:  2014-06-01       Impact factor: 3.633

6.  Retinopathy is associated with higher glycaemia in maturity-onset type diabetes.

Authors:  J Howard-Williams; R M Hillson; A Bron; P Awdry; J I Mann; T D Hockaday
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

7.  Blood glucose and diabetic retinopathy: a critical appraisal of new evidence.

Authors:  C D Mulrow; M J Lichtenstein
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

8.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

9.  Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.

Authors:  R G Nelson; J M Newman; W C Knowler; M L Sievers; C L Kunzelman; D J Pettitt; C D Moffett; S M Teutsch; P H Bennett
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

10.  Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia.

Authors:  B Vasquez; E V Flock; P J Savage; M Nagulesparan; L J Bennion; H R Baird; P H Bennett
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.